Company

Our
Company

We are more than a radioisotope supplier. We are solving the challenges facing U.S. radioisotope customers and constantly evolving to meet changing needs.

IN OUR EFFORTS TO DELIVER
CREATIVE SOLUTIONS, WE
CLEARLY DEFINE

WHO
WE ARE

We are innovators who revolutionized the reliable production of Mo-99. We are dedicated to preserving the environment using non-uranium production methods. We are pioneers working with industry leaders to develop and commercialize new diagnostics and therapeutics that will serve the next generation of medical advances for patients.

THE RADIOPHARMACEUTICAL MARKET
DEMANDS CREATIVE, ORIGINAL
THINKING, LIKE THAT PIONEERED BY OUR

LEADERSHIP
TEAM

Our executive team brings proven experience and expertise in developing and commercializing innovative nuclear medicine products and technologies.

LATEST NEWS, PRESS RELEASES & EVENTS


Press Releases - Nov 18, 2021
NorthStar Medical Radioisotopes and IBA Sign Contract for Rhodotron® Electron Beam Accelerator for Commercial Production of Therapeutic Radioisotope Actinium-225 (Ac-225)

Press Releases - Oct 14, 2021
NorthStar Medical Radioisotopes Expansion Event Unveils Advanced Radioisotope Production Equipment and Breaks Ground on First-in-Kind Therapeutic Radioisotope Production Facility

Press Releases - Oct 7, 2021
NorthStar Medical Radioisotopes Announces Launch of New Website to Showcase Company’s Expanding Commercial Success, Pipeline Progress and Plans for the Future
Mar 18, 2022 - Mar 21, 2022
Meeting
American Pharmacists Association (APhA) 2022 Annual Meeting & Exposition
Attending, Speaking, Exhibiting